Table 1 Correlation of the expression of AL355338 in NSCLC with clinicopathologic features
Characteristics | Â | AL355338 | P value | |
|---|---|---|---|---|
Low (n) | High (n) | |||
Age (years) | ||||
 < 60 | 34 (42.5%) | 16 | 18 | 0.54 |
 ≥ 60 | 46 (57.5%) | 21 | 25 |  |
Gender | ||||
 Male | 41 (51.2%) | 17 | 24 | 0.26 |
 Female | 39 (48.8%) | 20 | 19 |  |
TNM stage | ||||
 I | 23 (28.7%) | 19 | 4 | < 0.01** |
 II | 19 (23.8%) | 14 | 5 |  |
 III | 22 (27.5%) | 4 | 18 |  |
 IV | 16 (20.0%) | 0 | 16 |  |
T stage | ||||
 T1 | 21 (26.3%) | 12 | 9 | 0.04* |
 T2 | 37 (46.3%) | 19 | 18 |  |
 T3 | 16 (20.0%) | 5 | 11 |  |
 T4 | 6 (7.5%) | 1 | 5 |  |
N stage | ||||
 N0 | 32 (40.0%) | 23 | 9 | 0.03* |
 N1 | 17 (21.3%) | 7 | 10 |  |
 N2 | 23 (28.7%) | 6 | 17 |  |
 N3 | 8 (10.0%) | 1 | 7 |  |
M stage | ||||
 M0 | 65 (81.3%) | 37 | 28 | < 0.01** |
 M1 | 15 (18.8%) | 0 | 15 |  |
Mortality | ||||
 Survive | 30 (37.5%) | 17 | 13 | 0.04* |
 Die | 50 (62.5%) | 20 | 30 |  |
Histological grade | ||||
 I | 5 (6.2%) | 2 | 3 | 0.38 |
 II | 42 (52.5%) | 24 | 18 |  |
 III | 33 (41.3%) | 11 | 22 |  |
Tumor location | ||||
 Left | 35 (43.8%) | 15 | 20 | 0.55 |
 Right | 45 (56.2%) | 22 | 23 |  |